Dr. David Chu is an international key opinion leader in areas of uveitis, ocular immunology and cornea surgeries. He is currently acting as a principal investigator in numerous research projects and clinical trials. In 2006, Dr. Chu was the first to report the outbreak of Fusarium Keratitis associated with use of Renu with Moisture Loc contact lens solution in America to the Federal Health Authority. After the FDA & CDC investigation, he was credited for identifying the link between Bausch & Lomb contact lens solution and the sight threatening fungal cornea infection which was featured in the NY Times.
He lectures and teaches nationally and abroad along with providing cutting edge patient care. He is the first surgeon to perform DMEK and DSEK procedures, the least invasive forms of cornea transplantation, in the New York and New Jersey metro area. Dr. Chu also serves as Team Physician for the NY Jets.
Create an account now to our Online Portal! so that you can request your appointments, order your contacts, send and receive secure messages, view educational materials on your eyes, and pay your bills! Creating a secure account is fast, easy, convenient, and private!
I am an ophthalmologist specializing in ocular immunology and corneal transplantation. I am also a professor of ophthalmology at the New Jersey Medical School of Rutgers University, where I teach residents and medical students. My office is located in Palisades Park, New Jersey. I conduct research and clinical trials and lecture nationally and internationally. I strive to provide cutting-edge medical and surgical options for patients with complex ocular conditions.
“My research interests can be categorized into three main areas, ocular infections, immunology and ocular surface disorders. I am interested in understanding the pathophysiology of cornea infection; in particular, contact lens associated microbial keratitis, and its treatments. I am also studying new ways of diagnosing and treating uveitis and scleritis, and their associated condition, including sarcoidosis and juvenile idiopathic arthritis. Corneal transplant rejection is also an area I am actively researching. Ocular surface disorders, such as keratoconjunctivitis sicca and pterygium, are of interest as well and novel use of amniotic membrane for chemical injuries among other conditions is being studied.”